GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polarean Imaging PLC (LSE:POLX) » Definitions » Debt-to-Asset

Polarean Imaging (LSE:POLX) Debt-to-Asset : 0.02 (As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Polarean Imaging Debt-to-Asset?

Polarean Imaging's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was £0.11 Mil. Polarean Imaging's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was £0.12 Mil. Polarean Imaging's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2023 was £12.43 Mil. Polarean Imaging's debt to asset for the quarter that ended in Jun. 2023 was 0.02.


Polarean Imaging Debt-to-Asset Historical Data

The historical data trend for Polarean Imaging's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polarean Imaging Debt-to-Asset Chart

Polarean Imaging Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-Asset
Get a 7-Day Free Trial - 0.02 0.02 0.01 0.02

Polarean Imaging Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.01 0.02 0.02 0.02

Competitive Comparison of Polarean Imaging's Debt-to-Asset

For the Medical Devices subindustry, Polarean Imaging's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polarean Imaging's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Polarean Imaging's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Polarean Imaging's Debt-to-Asset falls into.



Polarean Imaging Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Polarean Imaging's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Polarean Imaging's Debt-to-Asset for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Polarean Imaging  (LSE:POLX) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Polarean Imaging Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Polarean Imaging's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Polarean Imaging (LSE:POLX) Business Description

Traded in Other Exchanges
Address
27-28 Eastcastle Street, London, GBR, W1W 8DH
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment being the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives most of the revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.

Polarean Imaging (LSE:POLX) Headlines

No Headlines